Join the club for FREE to access the whole archive and other member benefits.

Radiotherapeutic self-propelled nanobots shrink bladder tumors 90% in mice

New, more efficient approach for personalized bladder cancer treatment

15-Jan-2024

Key points from article :

Single dose of urea-powered, radionuclide-carrying nanorobots successfully reduced bladder tumor size by 90% in mice.

“Treatment approach would enhance efficiency, reducing the length of hospitalization and treatment costs," - research lead Samuel Sánchez.

Nanobots' self-propulsion helps them reach all areas of the bladder, accumulate in tumors, and deliver targeted radiation therapy.

Developed new techniques to visualize nanobots within bladders and tumors, overcoming limitations of conventional imaging.

“Localized administration reduces the probability of adverse effects, and the high accumulation favours the radiotherapeutic effect,” - research co-lead Jordi Llop.

Even low doses of radiation delivered by nanobots were effective in reducing tumor size.

Researchers are investigating whether treated tumors recur and exploring the use of other radioisotopes for therapy.

Study by IBEC and CIC biomaGUNE, published in Nature Nanotechnology.

Mentioned in this article:

Click on resource name for more details.

CIC biomaGUNE

Non-profit research center based in San Sebastián, Spain

Institute for Bioengineering of Catalonia (IBEC)

International CERCA research centre

Jordi Llop

Principal investigator, Head of Radiochemistry at CIC biomaGUNE

Nature Nanotechnology

A journal providing information from all aspects of nanoscale science and technology.

Samuel Sánchez Ordóñez

ICREA Research Professor at Institute for Bioengineering of Catalonia and at Max Planck Institute Intelligent Systems

Topics mentioned on this page:
Nanobots, Cancer
Radiotherapeutic self-propelled nanobots shrink bladder tumors 90% in mice